What is the primary benefit of laser therapy in conjunction with surgical/nonsurgical therapy for peri-implant diseases?

The primary benefit of laser therapy when used alongside surgical or nonsurgical treatment for peri-implant diseases lies in its ability to enhance overall therapeutic outcomes rather than solely focusing on plaque reduction. While laser therapy may show minimal direct impact on plaque index reduction, its true advantage is in the other areas where it contributes significantly.

Laser therapy is beneficial for its antibacterial effect, promoting healthy tissue regeneration and aiding in the reduction of inflammation surrounding the implant. This leads to improved clinical outcomes, such as better healing and reduced pocket depth. It can effectively prepare the implant surface and promote soft tissue reattachment, ultimately addressing the underlying causes of peri-implant diseases.

Presenting laser therapy as a mono therapy for failing implants does not capture its role as a supportive adjunct to existing surgical procedures. Similarly, significant reductions in periodontal disease as a standalone outcome are generally not attributable to laser use specifically in conjunction with implant therapy. Major improvements in clinical attachment level can be influenced by laser therapy, but it is generally within the context of a combined therapeutical approach rather than a single-agent intervention.

Thus, while it may seem that the answer indicating minimal benefit in plaque index reduction captures a critique of laser therapy, the reality is that this perspective allows for the recognition of laser therapy’s broader benefits,